Synopsis of recent research by authors named "Qijie Ran"
- Recent research by Qijie Ran focuses on the progression and treatment of multiple myeloma (MM), particularly examining the role of circular RNA_0003489 as a biomarker and its association with treatment response and survival in newly diagnosed patients receiving bortezomib-based induction therapy.
- The author has also explored innovative strategies in hematological cancer treatment, developing potent molecular glue degraders targeting multiple neosubstrates to combat drug resistance and hematological toxicities, highlighting advances in personalized oncology.
- Additionally, Ran's studies include understanding the hypermethylation of miR-23 and its effects on uPA expression linked to MM cell proliferation, as well as the prognostic implications of CD25 expression in acute myeloid leukemia, within the broader context of cancer impacts during the COVID-19 pandemic.